Sign in
4

Changes in Ownership

ADARx Pharmaceuticals, Inc. Filed Acc 0001193125-26-408064

10% owner bought 1,600,000 shares at an average $17.00 ($27,200,000)

  • 10% owner acquired 8,336,661 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

SR ONE CAPITAL MANAGEMENT, LLC · 10% owner

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-28 Conversion : show line 1 in the form +3,334,938 3,334,938 I
2026-09-28 Conversion : show line 2 in the form +1,113,666 4,448,604 I
2026-09-28 Conversion : show line 3 in the form +512,897 4,961,501 I
2026-09-28 Purchase : show line 4 in the form +592,593 $17.00 $10,074,081 5,554,094 I
2026-09-28 Conversion : show line 5 in the form +1,538,691 1,538,691 I
2026-09-28 Purchase : show line 6 in the form +414,814 $17.00 $7,051,838 1,953,505 I
2026-09-28 Conversion : show line 7 in the form +1,667,468 1,667,468 I
2026-09-28 Conversion : show line 8 in the form +169,001 1,836,469 I
2026-09-28 Purchase : show line 9 in the form +592,593 $17.00 $10,074,081 592,593 I
Open-market purchases · 1,600,000 sh · avg $17.00 · $27,200,000

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2026-09-28 Conversion : show line 10 in the form Series B Preferred Stock −3,907,547 0 I
2026-09-28 Conversion : show line 11 in the form Series B-1 Preferred Stock −1,304,883 0 I
2026-09-28 Conversion : show line 12 in the form Series C Preferred Stock −600,962 0 I
2026-09-28 Conversion : show line 13 in the form Series C Preferred Stock −1,802,885 0 I
2026-09-28 Conversion : show line 14 in the form Series B Preferred Stock −1,953,773 0 I
2026-09-28 Conversion : show line 15 in the form Series B-1 Preferred Stock −198,019 0 I
Loading xslF345X06/ownership.xml…